Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Galderma Group AG - Unsponsored ADR (GALDY : OTC)

• Company Description    Galderma Group AG operates as a dermatology company. It delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare and therapeutic dermatology. Galderma Group AG is based in Zug, Switzerland. Number of Employees: 7,676

• Price / Volume Information    Yesterday's Closing Price: $42.49 Daily Weekly Monthly 20 Day Moving Average: 89,550 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 52 Week High: $46.31 52 Week Low: $31.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.92% -4.63% 12 Week 1.31% -1.46% Year To Date 2.51% -7.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Zahlerweg 10 - Zug,V8 6300 CHE ph: 41-58-455-8592 fax: - investors@galderma.com http://www.galderma.com

• General Corporate Information    Officers Flemming ?rnskov - Chief Executive Officer Thomas Ebeling - Chairman Sherilyn McCoy - Vice Chairman Thomas Dittrich - Chief Financial Officer Michael Bauer - Director Peer Information Galderma Group AG - Unsponsored ADR (BJCT) Galderma Group AG - Unsponsored ADR (CADMQ) Galderma Group AG - Unsponsored ADR (APNO) Galderma Group AG - Unsponsored ADR (UPDC) Galderma Group AG - Unsponsored ADR (IMTIQ) Galderma Group AG - Unsponsored ADR (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 36321W105 SIC: - Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.21 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.98 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 04/27/2026 - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: 43.36 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 1.19 Quick Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 0.93 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - 12.17 Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - - Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - 3.18 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - 0.33 Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - 24.81

Powered by Zacks Investment Research ©